Cargando…

Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy

SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrentino, Luca, Sileo, Annaclara, Daveri, Elena, Battaglia, Luigi, Guaglio, Marcello, Centonze, Giovanni, Sabella, Giovanna, Patti, Filippo, Villa, Sergio, Milione, Massimo, Belli, Filiberto, Cosimelli, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047023/
https://www.ncbi.nlm.nih.gov/pubmed/36980714
http://dx.doi.org/10.3390/cancers15061828
_version_ 1785013818137509888
author Sorrentino, Luca
Sileo, Annaclara
Daveri, Elena
Battaglia, Luigi
Guaglio, Marcello
Centonze, Giovanni
Sabella, Giovanna
Patti, Filippo
Villa, Sergio
Milione, Massimo
Belli, Filiberto
Cosimelli, Maurizio
author_facet Sorrentino, Luca
Sileo, Annaclara
Daveri, Elena
Battaglia, Luigi
Guaglio, Marcello
Centonze, Giovanni
Sabella, Giovanna
Patti, Filippo
Villa, Sergio
Milione, Massimo
Belli, Filiberto
Cosimelli, Maurizio
author_sort Sorrentino, Luca
collection PubMed
description SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a margin of >1 mm is still required to avoid locoregional recurrence in patients with a low response to neoadjuvant treatment. The findings of the present study might also increase the rate of sphincter-preserving rectal surgery in patients with a close/microscopically positive distal margin and a major/complete response to neoadjuvant chemoradiotherapy. ABSTRACT: Background: The adequate distal resection margin is still controversial in rectal cancer treated by neoadjuvant chemoradiotherapy (nCRT). The aim of this study was to assess the impact of a distal margin of ≤1 mm on locoregional recurrence-free survival (LRRFS). Methods: Among 255 patients treated with nCRT and surgery at the National Cancer Institute of Milan, 83 (32.5%) had a distal margin of ≤1 mm and 172 (67.5%) had a distal margin of >1 mm. Survival analyses were performed to assess the impact of distal margin on 5-year LRRFS, as well as Cox survival analysis. The role of distal margin on survival was analyzed according to different tumor regression grades (TRGs). Results: The overall 5-year LRRFS rate was 77.6% with a distal margin of ≤1 mm vs. 88.3% with a distal margin of >1 mm (Log-rank p = 0.09). Only stage ypT4 was an independent predictor of worse LRRFS (HR 15.14, p = 0.026). The 5-year LRRFS was significantly lower in TRG3–5 patients with a distal margin of ≤1 mm compared to those with a distal margin of >1 mm (68.5% vs. 84.2%, p = 0.027), while no difference was observed in case of TRG1–2 (p = 0.77). Conclusions: Low-responder rectal cancers after nCRT still require a distal margin of >1 mm to reduce the high likelihood of local relapse.
format Online
Article
Text
id pubmed-10047023
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100470232023-03-29 Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy Sorrentino, Luca Sileo, Annaclara Daveri, Elena Battaglia, Luigi Guaglio, Marcello Centonze, Giovanni Sabella, Giovanna Patti, Filippo Villa, Sergio Milione, Massimo Belli, Filiberto Cosimelli, Maurizio Cancers (Basel) Article SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a margin of >1 mm is still required to avoid locoregional recurrence in patients with a low response to neoadjuvant treatment. The findings of the present study might also increase the rate of sphincter-preserving rectal surgery in patients with a close/microscopically positive distal margin and a major/complete response to neoadjuvant chemoradiotherapy. ABSTRACT: Background: The adequate distal resection margin is still controversial in rectal cancer treated by neoadjuvant chemoradiotherapy (nCRT). The aim of this study was to assess the impact of a distal margin of ≤1 mm on locoregional recurrence-free survival (LRRFS). Methods: Among 255 patients treated with nCRT and surgery at the National Cancer Institute of Milan, 83 (32.5%) had a distal margin of ≤1 mm and 172 (67.5%) had a distal margin of >1 mm. Survival analyses were performed to assess the impact of distal margin on 5-year LRRFS, as well as Cox survival analysis. The role of distal margin on survival was analyzed according to different tumor regression grades (TRGs). Results: The overall 5-year LRRFS rate was 77.6% with a distal margin of ≤1 mm vs. 88.3% with a distal margin of >1 mm (Log-rank p = 0.09). Only stage ypT4 was an independent predictor of worse LRRFS (HR 15.14, p = 0.026). The 5-year LRRFS was significantly lower in TRG3–5 patients with a distal margin of ≤1 mm compared to those with a distal margin of >1 mm (68.5% vs. 84.2%, p = 0.027), while no difference was observed in case of TRG1–2 (p = 0.77). Conclusions: Low-responder rectal cancers after nCRT still require a distal margin of >1 mm to reduce the high likelihood of local relapse. MDPI 2023-03-17 /pmc/articles/PMC10047023/ /pubmed/36980714 http://dx.doi.org/10.3390/cancers15061828 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sorrentino, Luca
Sileo, Annaclara
Daveri, Elena
Battaglia, Luigi
Guaglio, Marcello
Centonze, Giovanni
Sabella, Giovanna
Patti, Filippo
Villa, Sergio
Milione, Massimo
Belli, Filiberto
Cosimelli, Maurizio
Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title_full Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title_fullStr Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title_full_unstemmed Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title_short Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
title_sort impact of microscopically positive (≤1 mm) distal margins on disease recurrence in rectal cancer treated by neoadjuvant chemoradiotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047023/
https://www.ncbi.nlm.nih.gov/pubmed/36980714
http://dx.doi.org/10.3390/cancers15061828
work_keys_str_mv AT sorrentinoluca impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT sileoannaclara impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT daverielena impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT battaglialuigi impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT guagliomarcello impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT centonzegiovanni impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT sabellagiovanna impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT pattifilippo impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT villasergio impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT milionemassimo impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT bellifiliberto impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy
AT cosimellimaurizio impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy